CA2500521A1 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides Download PDF

Info

Publication number
CA2500521A1
CA2500521A1 CA002500521A CA2500521A CA2500521A1 CA 2500521 A1 CA2500521 A1 CA 2500521A1 CA 002500521 A CA002500521 A CA 002500521A CA 2500521 A CA2500521 A CA 2500521A CA 2500521 A1 CA2500521 A1 CA 2500521A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
protein
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002500521A
Other languages
English (en)
French (fr)
Inventor
Y. Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A. Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J. Xue
Gezhi Weng
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2500521A1 publication Critical patent/CA2500521A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002500521A 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides Abandoned CA2500521A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/416,186 2002-10-02
US41618602P 2002-10-22 2002-10-22
PCT/US2003/030720 WO2004080148A2 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides

Publications (1)

Publication Number Publication Date
CA2500521A1 true CA2500521A1 (en) 2004-09-23

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002500521A Abandoned CA2500521A1 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides

Country Status (5)

Country Link
EP (1) EP1556490A4 (de)
JP (1) JP2006517094A (de)
AU (1) AU2003303305A1 (de)
CA (1) CA2500521A1 (de)
WO (1) WO2004080148A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
ATE528397T1 (de) * 2003-08-08 2011-10-15 Perseus Proteomics Inc Bei krebs überexprimiertes gen
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
WO2005030953A1 (ja) 2003-09-30 2005-04-07 Daiichi Pharmaceutical Co., Ltd. テトラヒドロ葉酸合成酵素遺伝子
ATE466106T1 (de) 2003-10-10 2010-05-15 Deutsches Krebsforsch Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen
US8609358B2 (en) * 2003-11-03 2013-12-17 Systagenix Wound Management (Us), Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
EP1712563A4 (de) * 2004-01-27 2008-05-28 Medical & Biol Lab Co Ltd Verfahren zur isolierung von monozyten
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
CA2555340A1 (en) * 2004-02-12 2005-09-01 Lexicon Genetics Incorporated Gene disruptions, compositions and methods relating thereto
CA2571080C (en) * 2004-06-18 2013-05-28 Duke University Modulators of odorant receptors
EP1778842B8 (de) 2004-07-22 2012-03-21 Five Prime Therapeutics, Inc. Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
US20090087474A1 (en) * 2005-01-07 2009-04-02 Petersen Thomas N Therapeutic use of growth factors,nsg29 and nsg31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
HUE027179T2 (en) 2006-10-20 2016-10-28 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Angiogenesis and vasculogenesis modulator for Rspond
WO2008106709A1 (en) * 2007-03-07 2008-09-12 The Council Of The Queensland Institute Of Medical Research NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
ES2537323T3 (es) 2007-08-20 2015-06-05 Oncotherapy Science, Inc. Péptido CDCA1 y agente farmacéutico que lo comprende
US7858759B2 (en) 2007-10-04 2010-12-28 Zymogenetics, Inc. Anti-zB7H6 antibody-drug conjugates
EP2207555B1 (de) 2007-10-05 2013-07-24 InDex Pharmaceuticals AB Oligonukleotide zur behandlung oder linderung von ödem
TR201802233T4 (tr) 2007-10-25 2018-03-21 Toray Industries İmmün cevap indükleyiciler.
JP5572938B2 (ja) * 2007-10-25 2014-08-20 東レ株式会社 免疫誘導剤
PT3106873T (pt) * 2007-10-25 2019-10-18 Toray Industries Método para a deteção de cancro
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US20110053852A1 (en) * 2007-12-21 2011-03-03 Paul Klotman Use of podocan protein in treating cardiovascular diseases
TWI526219B (zh) * 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2872532A4 (de) 2012-07-10 2016-04-13 Oncotherapy Science Inc Cdca1-epitoppeptide für th1-zellen und impfstoffe damit
WO2014100740A1 (en) 2012-12-21 2014-06-26 Seattle Genetics, Inc. Anti-ntb-a antibodies and related compositions and methods
EP3971211A1 (de) * 2015-07-13 2022-03-23 Compugen Ltd. Hide1-zusammensetzungen und verfahren
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (zh) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 癌胚抗原特异性tcr基因修饰的t细胞及其抑癌用途
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
CA3121247A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009474A1 (en) * 2000-05-24 2004-01-15 Leach Martin D. Novel human polynucleotides and polypeptides encoded thereby

Also Published As

Publication number Publication date
WO2004080148A3 (en) 2005-03-31
JP2006517094A (ja) 2006-07-20
EP1556490A2 (de) 2005-07-27
AU2003303305A1 (en) 2004-09-30
WO2004080148A2 (en) 2004-09-23
EP1556490A4 (de) 2006-04-05

Similar Documents

Publication Publication Date Title
US6743619B1 (en) Nucleic acids and polypeptides
US6610536B2 (en) Nucleic acids and polypeptides
CA2440257A1 (en) Novel nucleic acids and polypeptides
WO2001064835A2 (en) Novel nucleic acids and polypeptides
EP1556490A2 (de) Neue nukleinsäuren und polypeptide
WO2002031111A2 (en) Novel nucleic acids and polypeptides
WO2001088088A2 (en) Novel nucleic acids and polypeptides
CA2461280A1 (en) Novel nucleic acids and polypeptides
US20040053245A1 (en) Novel nucleic acids and polypeptides
WO2002074961A1 (en) Novel nucleic acids and polypeptides
AU2734401A (en) Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
CA2401505A1 (en) Novel nucleic acids and polypeptides
US20020150898A1 (en) Novel nucleic acids and polypeptides
WO2004087874A2 (en) Novel nucleic acids and polypeptides
WO2002018424A9 (en) Nucleic acids and polypeptides
WO2002044340A2 (en) Novel nucleic acids and polypeptides
WO2001053453A2 (en) Novel bone marrow nucleic acids and polypeptides
EP1430146A2 (de) Neue nukleinsäuren und polypeptide
US20050170374A1 (en) Novel nucleic acids and polypeptides
CA2409164A1 (en) Novel nucleic acids and polypeptides
CA2406121A1 (en) Novel nucleic acids and polypeptides
WO2001057261A9 (en) Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
WO2001057187A2 (en) Novel bone marrow nucleic acids and polypeptides
WO2001064840A2 (en) Novel bone marrow nucleic acids and polypeptides
US20030073099A1 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
FZDE Discontinued